WHO ICTRP trial
Efficacy and Safety of SGLT2 inhibitors in patients with type 1 diabete.
JPRN-UMIN000044317 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000044317 |
|---|---|
| Public title | Efficacy and Safety of SGLT2 inhibitors in patients with type 1 diabete. |
| Scientific title | Efficacy and Safety of SGLT2 inhibitors in patients with type 1 diabete. - SGLT2i in T1DM,Sapporo |
| Primary sponsor | Hokkaido University Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Observational |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | type 1 diabetes |
| Registration date | May 28, 2021 |
| Target size | 200 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: